Pharmaniaga Bhd (XKLS:7081) E10: RM-0.09 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:7081 Pharmaniaga Bhd XKLS:7081
45 GF Score
Price RM1.18
GF Value RM0.73
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Pharmaniaga Bhd E10?

Pharmaniaga Bhd XKLS:7081 45 E10 is RM-0.09 as of Mar. 2026. GuruFocus rates XKLS:7081 with a GF Score™ of 45/100 and a GF Value™ of RM0.73 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Pharmaniaga Bhd's adjusted earnings per share data for the three months ended in Mar. 2026 was RM0.024. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is RM-0.09 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -38.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Pharmaniaga Bhd was -38.70% per year. The lowest was -38.70% per year. And the median was -38.70% per year.

As of today (2026-07-19), Pharmaniaga Bhd's current stock price is RM1.18. Pharmaniaga Bhd's E10 for the quarter that ended in Mar. 2026 was RM-0.09. Pharmaniaga Bhd's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Pharmaniaga Bhd was 33.89. The lowest was 5.86. And the median was 16.58.


Pharmaniaga Bhd  (XKLS:7081) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Pharmaniaga Bhd was 33.89. The lowest was 5.86. And the median was 16.58.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Pharmaniaga Bhd E10 Related Terms


Pharmaniaga Bhd E10 Historical Data

* Premium members only.

The historical data trend for Pharmaniaga Bhd's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmaniaga Bhd E10 Chart

Pharmaniaga Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 -0.03 -0.06 -0.06 -0.08

Pharmaniaga Bhd Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.07 -0.08 -0.08 -0.09

XKLS:7081 vs MCK, CAH, COR: E10 Comparison

For the Medical Distribution subindustry, Pharmaniaga Bhd's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaniaga Bhd Shiller PE Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pharmaniaga Bhd's Shiller PE Ratio falls into.


XKLS:7081
45GF Score
Pharmaniaga Bhd XKLS:7081
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmaniaga Bhd E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharmaniaga Bhd's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.024/330.2130*330.2130
=0.024

Current CPI (Mar. 2026) = 330.2130.

Pharmaniaga Bhd Quarterly Data

per share eps CPI Adj_EPS
201606 0.034 241.018 0.047
201609 0.030 241.428 0.041
201612 -0.002 241.432 -0.003
201703 0.043 243.801 0.058
201706 0.022 244.955 0.030
201709 0.008 246.819 0.011
201712 0.050 246.524 0.067
201803 0.040 249.554 0.053
201806 0.012 251.989 0.016
201809 0.034 252.439 0.044
201812 0.010 251.233 0.013
201903 0.045 254.202 0.058
201906 0.021 256.143 0.027
201909 0.001 256.759 0.001
201912 -0.407 256.974 -0.523
202003 0.051 258.115 0.065
202006 0.023 257.797 0.029
202009 0.003 260.280 0.004
202012 -0.015 260.474 -0.019
202103 0.053 264.877 0.066
202106 0.031 271.696 0.038
202109 0.113 274.310 0.136
202112 0.194 278.802 0.230
202203 0.063 287.504 0.072
202206 0.002 296.311 0.002
202209 -0.032 296.808 -0.036
202212 -1.462 296.797 -1.627
202303 0.006 301.836 0.007
202306 0.004 305.109 0.004
202309 -0.109 307.789 -0.117
202312 -0.077 306.746 -0.083
202403 0.053 312.332 0.056
202406 0.006 314.175 0.006
202409 0.208 315.301 0.218
202412 0.005 315.605 0.005
202503 0.061 319.799 0.063
202506 0.008 322.561 0.008
202509 0.014 324.800 0.014
202512 0.011 324.054 0.011
202603 0.024 330.213 0.024

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of RM-0.09 mean?
Pharmaniaga Bhd (XKLS:7081) has a E10 of RM-0.09 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pharmaniaga Bhd and its competitors.
Is Pharmaniaga Bhd's E10 too high?
Pharmaniaga Bhd's current E10 is RM-0.09. Overall, Pharmaniaga Bhd has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's E10 compare to MCK and CAH?
Pharmaniaga Bhd's E10 of RM-0.09 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Distribution company?
A good E10 depends on the Medical Distribution industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Pharmaniaga Bhd and its competitors. Pharmaniaga Bhd's current E10 is RM-0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.73, compared to a current price of RM1.18 — trading 61.6% above its estimated fair value. The current E10 is RM-0.09. Pharmaniaga Bhd's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current E10 is RM-0.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued. The current stock price of RM1.18 is trading 61.6% above its estimated GF Value™ of RM0.73. GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.

Key valuation signals for XKLS:7081:

  • E10: RM-0.09
  • GF Value™: RM0.73 vs. price of RM1.18 (61.6% above fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pharmaniaga Bhd Business Description

Address No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja, Seksyen 7, Selatan, Shah Alam, SGR, MYS, 40000
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
45GF Score

Get the complete analysis for XKLS:7081

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM1.18
Price
RM0.73
GF Value